Positron Emission Tomographic Scanning Predicts Survival After Induction Chemotherapy for Esophageal Carcinoma

Annals of Thoracic Surgery

Volumn 84, Issue 2, 2007, Pages 393-400

  Port, Jeffrey L ^a   Lee, Paul C ^a   Korst, Robert J ^a   Liss, Yaakov ^a   Meherally, Danish ^a   Christos, Paul ^a   Mazumdar, Madhu ^a   Altorki, Nasser K ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE INTERVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447559791     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.03.094     Document Type: Article

References (24)

1. Jemal A., Murray T., Ward E., et al. Cancer Statistics, 2005. CA Cancer J Clin 55 (2005) 259
2. Muller J.M., Erasmi H., Stelzner M., et al. Surgical therapy of oesophageal carcinoma. Br J Surg 77 (1990) 845-857
3. Roth J.A., Pass H.I., Flanagan M.M., Graeber G.M., Rosenberg J.C., and Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96 (1988) 242-248
4. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
5. Naunheim K.S., Petrosku P.J., Roy T.S., Schlueter J.M., Kim H., and Baue A.E. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 59 (1995) 1085-1090
6. Kelson D.P., Ginsburg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
7. Swisher S.G., Maish M., Erasmus J.J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78 (2004) 1152-1160
8. Zuccaro G., Rice T.W., and Goldbaum J. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94 (1999) 906-912
9. Kaliff V., Hicks R.J., MacManus M.P., et al. Clinical impact of (18)F-fluorodeoxyglucose positron emission tomography in patients with non-small cell lung cancer; a prospective study. J Clin Oncol 19 (2001) 111-118
10. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small cell lung cancer with positron emission tomography. N Engl J Med 343 (2000) 254-261
11. Port E.R., Yeung H., Gonen M., et al. 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma. Ann Surg Oncol 13 (2006) 677-684 Epub 2006 Mar 16.
12. Mukai K., Ishida Y., Okajima K., Isozaki H., Morimoto T., and Nishiyama S. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer 9 (2006) 192-196
13. Whiteford M.H., Whiteford H.M., Yee L.F., et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43 (2000) 759-770
14. Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1053-1059 Nov 15. Epub 2005 Jun 20.
15. Wieder H.A., Beer A.J., Lordick F., et al. Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 46 (2005) 2029-2034
16. Brink I., Hentschel M., Bley T.A., et al. A. Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. Eur J Surg Oncol 30 (2004) 544-550
17. Cerfolio R.J., Bryant A.S., Ohja B., Bartolucci A.A., and Eloubeidi M.A. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129 (2005) 1232-1241
18. Downey R.J., Akhurst T., Ilson D., et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 21 (2003) 428-432
19. Rasanen J.V., Sihvo E.I., Knuuti M.J., et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 10 (2003) 954-960
20. Korst R.J., Kansler A.L., Port J.L., Lee P.C., Kerem Y., and Altorki N.K. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg 82 (2006) 480-485
21. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 9319 (2002) 1727-1733
22. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
23. Levine E.A., Farmer M.R., Clark P., et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 243 (2006) 472-478
24. Swisher S.G., Erasmus J., Maish M., et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101 (2004) 1776-1785